أسيل سيوف في 22:24، 12 أغسطس 2013

2013-08-12T22:24:50Z

→ مراجعة أقدم		مراجعة 22:24، 12 أغسطس 2013
سطر 1:		سطر 1:
	{{Navbox		{{Navbox
	\| name = ~~Glutamatergics~~		\| name = غلوتامينات
	\| title = [[Glutamate]]rgics [https://en.wikipedia.org/wiki/Template:Glutamatergics القالب الانكليزي]		\| title = [[Glutamate]]rgics [https://en.wikipedia.org/wiki/Template:Glutamatergics القالب الانكليزي]
	\|listclass = hlist		\|listclass = hlist

أسيل سيوف: نقل أسيل سيوف صفحة قالب:Glutamatergics إلى قالب:غلوتامينات

2013-08-12T22:24:13Z

نقل أسيل سيوف صفحة قالب:Glutamatergics إلى قالب:غلوتامينات

→ مراجعة أقدم	مراجعة 22:24، 12 أغسطس 2013
(لا فرق)

أسيل سيوف في 22:22، 12 أغسطس 2013

2013-08-12T22:22:46Z

→ مراجعة أقدم		مراجعة 22:22، 12 أغسطس 2013
سطر 1:		سطر 1:
	{{Navbox		{{Navbox
	\| name = Glutamatergics		\| name = Glutamatergics
	\| title = [[Glutamate]]rgics		\| title = [[Glutamate]]rgics [https://en.wikipedia.org/wiki/Template:Glutamatergics القالب الانكليزي]
	\|listclass = hlist		\|listclass = hlist
	\| groupstyle = background: LightYellow		\| groupstyle = background: LightYellow

أسيل سيوف: أنشأ الصفحة ب'{{Navbox | name = Glutamatergics | title = Glutamatergics |listclass = hlist | groupstyle = background: LightYellow | state = collapsed | group1 = Ionotropic...'

2012-10-01T14:47:44Z

أنشأ الصفحة ب'{{Navbox | name = Glutamatergics | title = Glutamatergics |listclass = hlist | groupstyle = background: LightYellow | state = collapsed | group1 = Ionotropic...'

صفحة جديدة

{{Navbox
| name = Glutamatergics
| title = [[Glutamate]]rgics
|listclass = hlist
| groupstyle = background: LightYellow
| state = collapsed

| group1 = [[Ionotropic]]
| list1 = {{Navbox subgroup
| groupstyle = background: LightYellow

| group1 = [[AMPA receptor|AMPA]]
| list1 =
* '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]]
* [[AMPA]]
* [[Domoic acid]]
* [[Quisqualic acid]]; ''[[Positive allosteric modulator]]s:'' [[Aniracetam]]
* [[Cyclothiazide]]
* [[CX-516]]
* [[CX-546]]
* [[CX-614]]
* [[CX-691]]
* [[CX-717]]
* [[Diazoxide]]
* [[Hydrochlorothiazide|HCTZ]]
* [[IDRA-21]]
* [[LY-392,098]]
* [[LY-404,187]]
* [[LY-451,395]]
* [[LY-451,646]]
* [[LY-503,430]]
* [[Org 26576]]
* [[Oxiracetam]]
* [[PEPA (drug)|PEPA]]
* [[Piracetam]]
* [[Pramiracetam]]
* [[S-18986]]
* [[Sunifiram]]
* [[Unifiram]] '''Antagonists:''' [[ATPO]]
* [[Barbiturates]]
* [[BGG492]]
* [[Caroverine]]
* [[CNQX]]
* [[DNQX]]
* [[GYKI-52466]]
* [[NBQX]]
* [[Perampanel]]
* [[Talampanel]]
* [[Tezampanel]]
* [[Topiramate]]; ''[[Negative allosteric modulator]]s:'' [[GYKI-53,655]]

| group2 = [[NMDA receptor|NMDA]]
| list2 =
* '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]
* [[Glutamate]]
* [[Homoquinolinic acid]]
* [[Ibotenic acid]]
* [[NMDA]]
* [[Quinolinic acid]]
* [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]
* [[ACPC]]
* [[ACPD]]
* [[Alanine]]
* [[Carboxycyclopropylglycine|CCG]]
* [[Cycloserine]]
* [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]
* [[Fluoroalanine]]
* [[Glycine]]
* [[HA-966]]
* [[L-687,414]]
* [[Milacemide]]
* [[Sarcosine]]
* [[Serine]]
* [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]
* [[Spermidine]]
* [[Spermine]] '''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]
* [[AP-7 (drug)|AP7]]
* [[CGP-37849]]
* [[CGP-39551]]
* [[CGP-39653]]
* [[CGP-40116]]
* [[CGS-19755]]
* [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]
* [[LY-233,053]]
* [[LY-235,959]]
* [[LY-274,614]]
* [[MDL-100,453]]
* [[Midafotel|Midafotel (d-CPPene)]]
* [[NPC-12,626]]
* [[NPC-17,742]]
* [[PBPD]]
* [[PEAQX]]
* [[Perzinfotel]]
* [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]
* [[SDZ-220581]]
* [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]
* [[Caroverine]]
* [[Dexanabinol]]
* [[FPL-12495]]
* [[FR-115,427]]
* [[Hodgkinsine]]
* [[Magnesium]]
* [[MDL-27,266]]
* [[NPS-1506]]
* [[Psychotridine]]
* [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]
* [[3-MeO-PCP]]
* [[8a-Phenyldecahydroquinoline|8A-PDHQ]]
* [[Alaproclate]]
* [[Amantadine]]
* [[Aptiganel]]
* [[ARL-12,495]]
* [[ARL-15,896-AR]]
* [[ARL-16,247]]
* [[Budipine]]
* [[Delucemine]]
* [[Dexoxadrol]]
* [[Dextrallorphan]]
* [[Dieticyclidine]]
* [[Dizocilpine]]
* [[Endopsychosin]]
* [[Esketamine]]
* [[Etoxadrol]]
* [[Eticyclidine]]
* [[Gacyclidine]]
* [[Ibogaine]]
* [[Indantadol]]
* [[Ketamine]]
* [[Ketobemidone]]
* [[Loperamide]]
* [[Memantine]]
* [[Meperidine|Meperidine (Pethidine)]]
* [[Methadone]] ([[Levomethadone]])
* [[Methorphan]] ([[Dextromethorphan]]
* [[Levomethorphan]])
* [[Methoxetamine]]
* [[Milnacipran]]
* [[Morphanol]] ([[Dextrorphan]]
* [[Levorphanol]])
* [[NEFA (drug)|NEFA]]
* [[Neramexane]]
* [[Nitrous oxide]]
* [[Noribogaine]]
* [[Orphenadrine]]
* [[PCPr]]
* [[Phencyclamine]]
* [[Phencyclidine]]
* [[Propoxyphene]]
* [[Remacemide]]
* [[Rhynchophylline]]
* [[Riluzole]]
* [[Rimantadine]]
* [[Rolicyclidine]]
* [[Sabeluzole]]
* [[Tenocyclidine]]
* [[Tiletamine]]
* [[Tramadol]]
* [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]
* [[ACEA-1328]]
* [[1-Aminocyclopropanecarboxylic acid|ACPC]]
* [[Carisoprodol]]
* [[CGP-39653]]
* [[7-Chlorokynurenate|CKA]]
* [[DCKA]]
* [[Felbamate]]
* [[Gavestinel]]
* [[GV-196,771]]
* [[Kynurenic acid]]
* [[L-689,560]]
* [[L-701,324]]
* [[Lacosamide]]
* [[Licostinel]]
* [[LU-73,068]]
* [[MDL-105,519]]
* [[Meprobamate]]
* [[MRZ 2/576]]
* [[PNQX]]
* [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]
* [[CO-101,244|CO-101,244 (PD-174,494)]]
* [[CP-101,606]]
* [[Eliprodil]]
* [[Haloperidol]]
* [[Ifenprodil]]
* [[Isoxsuprine]]
* [[Nylidrin]]
* [[Ro8-4304]]
* [[Ro25-6981]]
* [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]
* [[Co 101676]]
* [[1,3-Diaminopropane|Diaminopropane]]
* [[Acamprosate]]
* [[Diethylenetriamine]]
* [[Huperzine A]]
* [[Putrescine]]
* [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]
* [[Diethyl ether]]
* [[Enflurane]]
* [[Ethanol|Ethanol (Alcohol)]]
* [[Halothane]]
* [[Isoflurane]]
* [[Methoxyflurane]]
* [[Toluene]]
* [[1,1,1-Trichloroethane|Trichloroethane]]
* [[2,2,2-Trichloroethanol|Trichloroethanol]]
* [[Trichloroethylene]]
* [[Xylene]]

| group3 = [[Kainate receptor|Kainate]]
| list3 =
* '''Agonists:''' [[5-Iodowillardiine]]
* [[ATPA]]
* [[Domoic acid]]
* [[Kainic acid]]
* [[LY-339,434]]
* [[SYM-2081]] '''Antagonists:''' [[BGG492]]
* [[CNQX]]
* [[DNQX]]
* [[LY-382,884]]
* [[NBQX]]
* [[NS102]]
* [[Tezampanel]]
* [[Topiramate]]
* [[UBP-302]]; ''Negative allosteric modulators:'' [[NS-3763]]

}}

| group2 = [[Metabotropic glutamate receptor|Metabotropic]]
| list2 = {{Navbox subgroup
| groupstyle = background: LightYellow

| group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]]
| list1 =
* '''Agonists:''' ''Non-selective:'' [[ACPD]]
* [[Dihydroxyphenylglycine|DHPG]]
* [[Quisqualic acid]]; ''mGlu1-selective:'' [[Ro01-6128]]
* [[Ro67-4853]]
* [[Ro67-7476]]
* [[VU-71]]; ''mGlu5-selective:'' [[ADX-47273]]
* [[CDPPB]]
* [[CHPG]]
* [[1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine|DFB]]
* [[VU-1545]] '''Antagonists:''' ''Non-selective:'' [[MCPG]]
* [[NPS-2390]]; ''mGlu1-selective:'' [[BAY 36-7620]]
* [[CPCCOEt]]
* [[LY-367,385]]
* [[LY-456,236]]; ''mGlu5-selective:'' [[CTEP]]
* [[Dipraglurant]]
* [[DMeOB]]
* [[LY-344,545]]
* [[SIB-1757]]
* [[SIB-1893]]; ''Negative allosteric modulators:'' [[Fenobam]]
* [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]]
* [[MTEP]]
* [[GRN-529]]

| group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]]
| list2 =
* '''Agonists:''' ''Non-selective:'' [[CBiPES]]
* [[DCG-IV]]
* [[Eglumegad]]
* [[LY-379,268]]
* [[LY-404,039]]
* [[LY-487,379]]
* [[MGS-0028]]; ''mGlu2-selective:'' [[Biphenylindanone A|BINA]]
* [[LY-566,332]] '''Antagonists:''' ''Non-selective:'' [[APICA (drug)|APICA]]
* [[EGLU]]
* [[HYDIA]]
* [[LY-307,452]]
* [[LY-341,495]]
* [[MCPG]]
* [[MGS-0039]]: ''mGlu2-selective:'' [[PCCG-4]]; ''mGlu3-selective:'' [[CECXG]]; ''Negative allosteric modulators:'' [[RO4491533]]

| group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]]
| list3 =
* '''Agonists:''' ''Non-selective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]]
* [[VU-001,171]]
* [[VU-0155,041]]; ''mGlu7-selective:'' [[AMN082]]; ''mGlu8-selective:'' [[DCPG]] '''Antagonists:''' ''Non-selective:'' [[CPPG]]
* [[MAP4 (drug)|MAP4]]
* [[MSOP (drug)|MSOP]]
* [[MPPG]]
* [[MTPG]]
* [[UBP-1112]]; ''mGlu7-selective:'' [[MMPIP]]

}}

| group3 = [[Glutamate transporter|Transporter]] [[Reuptake inhibitor|inhibitor]]s
| list3 = {{Navbox subgroup
| groupstyle = background: LightYellow

| group1 = [[Glutamate transporter|EAAT]]s
| list1 =
* [[Dihydrokainic acid|DHKA]]
* [[L-trans-Pyrrolidine-2,4-dicarboxylic acid|PDC]]
* [[WAY-213,613]]

| group2 = [[Vesicular glutamate transporters|vGluTs]]
| list2 =
* [[7-Chlorokynurenic acid|7-CKA]]
* [[Evans blue]]

}}

| group4 = Others
| list4 = {{Navbox subgroup
| groupstyle = background-color: LightYellow

| group1 = [[Precursor (chemistry)|Precursor]]s
| list1 =
* [[Glutamine|L-Glutamine]]

| group2 = [[Cofactor (biochemistry)|Cofactor]]s
| list2 =
* [[α-Ketoglutaric acid]]
* [[Iron]]
* [[Sulfur]]
* [[Vitamin B2]] (as [[Flavin adenine dinucleotide|FAD]] and [[Flavin mononucleotide|FMN]])
* [[Vitamin B3]] (as [[NADPH]])

| group3 = Others
| list3 =
* [[Theanine|L-Theanine]]

}}

}}
<noinclude>
[[تصنيف:جداول تصفح الأدوية]]
</noinclude>

قالب:غلوتامينات - تاريخ المراجعة

أسيل سيوف في 22:24، 12 أغسطس 2013

أسيل سيوف: نقل أسيل سيوف صفحة قالب:Glutamatergics إلى قالب:غلوتامينات

أسيل سيوف في 22:22، 12 أغسطس 2013

أسيل سيوف: أنشأ الصفحة ب'{{Navbox | name = Glutamatergics | title = Glutamatergics |listclass = hlist | groupstyle = background: LightYellow | state = collapsed | group1 = Ionotropic...'